NewTimeSpace News: HS Optimus Holdings announced on 20 July that all preconditions for the acquisition of a 30% equity interest in Medicorp Sdn Bhd have been fulfilled, and the acquisition was completed on 20 July.
NewTimeSpace (newtimespace.com) reported that on July 21, 2026, Hong Kong semiconductor stocks rebounded sharply, with SMIC(00981.HK) surging. As of 13:34, the stock was quoted at HKD 153.84, up 6.83%.
NewTimeSpace (newtimespace.com) reported that on July 21, 2026, the robotics theme rebounded sharply, with UBTECH (09880.HK) rising in choppy trading. As of 13:15, the stock was quoted at HKD 83.500, up 1.71%.
NewTimeSpace (newtimespace.com) News, On July 21, 2026, Hong Kong stock tech themes continued to strengthen. As of 10:34, the CSI Hong Kong Stock Connect Information Technology Combined Index (930967) surged 2.56%. Choice data shows that Hwabao WP CSI HK Equities Information Technology Integration ETF Initiating Feeder Fund (026755) rose 1.75% on July 20, 2026. In terms of fund shares, its total shares expanded from 89 million to 213 million units between March 3, 2026, and June 30, 2026, representing a growth of 124 million units over three months and achieving significant expansion.
NewTimeSpace News: On 21 July 2026, BIDU-SW(09888.HK) saw sluggish performance during morning trading. As of 11:18 a.m., the stock traded at HK$106.10, down 2.84%. Apollo Go and TPH signed a strategic cooperation agreement in Shanghai to jointly launch autonomous vehicle mobility services in Kazakhstan.
NewTimeSpace (newtimespace.com) News, On July 21, 2026, the Hong Kong Hang Seng Index weakened with volatility. As of 10:05, the GF HK Equities Hang Seng Composite Midcap Index Fund(LOF) (501303.SH) increased by 0.54%, achieving a cumulative gain of 2.62% so far this week.Data shows that the OTC fund for GF HK Equities Hang Seng Composite Midcap Index Fund(LOF)(501303.SH) is GF HK Equities Hang Seng Composite Midcap Index Fund(LOF)-A (501303), with linked funds: GF HK Equities Hang Seng Composite Midcap Index Fund(LOF)-E (018238) and GF HK Equities Hang Seng Composite Midcap Index Fund(LOF)-C (004996).
HKIC's 2025 Annual Report reveals total assets of HKD 69.7 billion, investment income exceeding HKD 6.4 billion (+175% YoY), and a net portfolio IRR of 14%. By June 2026, the corporation had invested in over 200 projects, leveraged market capital at a ratio exceeding 1:8, and supported 10 portfolio companies in their Hong Kong IPOs. Beyond robust financial returns, HKIC has generated significant local socio-economic benefits, including the creation of over 7,200 local jobs, massive commercial real estate leasing, and extensive academic collaborations. Moving forward, HKIC will deeply integrate into the national "15th Five-Year Plan," expand into frontier sectors like brain-computer interfaces and commercial aerospace, and continue leveraging its "patient capital" to drive the deep integration of tech and finance, thereby solidifying Hong Kong's comprehensive advantages in serving national strategies and competing in global technological innovation.
NewTimeSpace News: GEEKPLUS-W(02590.HK) will spend HKD 11.66 million to repurchase 1.2 million shares on Jul 20, 2026.
NewTimeSpace News: EVERG VEHICLE (00708.HK) announced that Mr. Xie Wu has resigned as Independent Non-executive Director and Chairman of the Audit, Nomination, Remuneration and Corporate Governance Committees with effect from 20 July 2026, to devote more time to his professional medical engagements. Following his resignation, the Company fails to satisfy several requirements under the Listing Rules.
NewTimeSpace News: SSY GROUP (02005.HK) announced that its gadobutrol active pharmaceutical ingredient (API) has obtained registration approval from the National Medical Products Administration (NMPA) for use in marketed finished pharmaceutical products. As an MRI contrast agent, gadobutrol is indicated for adults and paediatric patients of all ages, applied in contrast-enhanced MRI and MR angiography examinations for lesions across all body parts.
NewTimeSpace News: SUNSHINE PHARMA (06887.HK) announced that Mr. Zhang Yushuai, controlling shareholder and non-executive director, intends to purchase shares worth HK$300 million to HK$600 million on the open market within the next six months, via himself or entities under his control. As of the announcement date, Mr. Zhang holds approximately 51.11% of issued shares through direct and indirect interests. Separately, the Company repurchased 817,500 shares on 20 July at a total consideration of around HK$26.36 million.
NewTimeSpace News: On July 20, Lung Fung Group announced that for the three months ended June 30, 2026, retail sales through stores reached approximately HK$829.3 million, up approximately 21.2% year-on-year from HK$684.2 million, with store count increasing from 27 to 31; sales at 25 comparable stores reached HK$740.5 million, representing a same-store sales increase of 10.3%. The Board attributed the growth mainly to increased customer traffic and expanded retail network coverage, though consecutive rainy days in June had some impact on sales. The data is unaudited and represents preliminary internal information only.
NewTimeSpace News: On July 21, Huaqin Technology announced that the reduction plans disclosed on June 23 by shareholders Hainan Qinyuan, Hainan Chuangjian, and Hainan Huaxiao had been fully implemented; the three shareholders reduced a combined total of 4,105,624 shares (0.27% of total shares) through centralized competitive bidding from July 15 to July 20, with total cash proceeds of approximately RMB 319 million, including Hainan Huaxiao's reduction of 2,727,464 shares for approximately RMB 211.5 million at a price range of RMB 73.53–81.14 per share. Post-reduction, Hainan Qinyuan holds 4.57%, Hainan Chuangjian holds 4.41%, and Hainan Huaxiao holds 4.08%; all shares were obtained pre-IPO and through capital reserve conversion.
SF HOLDING(06936.HK) will spend CNY 54 million to repurchase 1.6 million shares on Jul 20, 2026 .
NewTimeSpace News: On July 20, SMIT Holdings announced that its wholly-owned subsidiary, as seller, agreed to sell its 5 million shares in Xingji (representing 3.9529%) to Shengshi Zhida and Jiutian Shengshi for a total consideration of approximately RMB 63.25 million (RMB 57.05 million under Transfer A and RMB 6.20 million under Transfer B). Upon completion, the Seller will no longer hold any Xingji equity; the Group expects to record an unaudited pre-tax disposal loss of approximately USD 1.4 million, with net proceeds of approximately USD 9.2 million to be applied to investment opportunities in emerging technologies and areas synergistic with existing businesses. The transaction aligns with the Group's strategy to cease EDA product R&D and reduce its EDA investment portfolio, and constitutes a discloseable transaction as the applicable percentage ratios exceed 5% but are below 25%.
NewTimeSpace News: On July 20, GigaDevice announced that the Beijing Xiaomi Zhizao Equity Investment Fund, in which it invested RMB 200 million in 2022 (planned total fundraising of RMB 10 billion, currently fully raised), held a partners' meeting on July 20, 2026, resolving to extend the investment period from four years to five years from the first closing date, with the annual management fee during the extended period adjusted to 2% of unexited project costs allocated to the respective partner. The Company stated that this aligns with the fund's actual operational circumstances and will not materially affect its daily operations or financial conditions.
